Filing Flows › GSK (GSK) › Q1 2026
GSK (GSK) Q1 2026 earnings results (first quarter 2026)
6-K filed Apr 29, 2026
GSK (GSK) reported revenue of $7.5B for the first quarter 2026 (Q1 2026). Operating margin was 29.5%, net earnings $1.6B (21.6% of revenue).
GSK, Q1 2026: revenue $7.5B, operating margin 29.5%, net earnings $1.6B, operating cash flow $1.4B. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $7.5B | — | — |
| Gross profit | $5.6B | — | — |
| Operating profit | $2.2B | — | — |
| Net earnings | $1.6B | — | — |
| Operating cash flow | $1.4B | — | — |
| Free cash flow | $1.1B | — | — |
What changed
Revenue was £7.5B in Q1 2026.
Gross margin was 74.2%. Operating profit was £2.2B, a 29.5% margin. Net earnings were £1.6B. The effective tax rate was 15.9%.
Operating cash flow was £1.4B, 76% of net income including minority interests. Working capital and other items used £0.42B. Capital expenditures of £0.22B left free cash flow of £1.1B.
Questions
What was GSK's revenue in the first quarter 2026?
GSK (GSK) reported revenue of $7.5B for the first quarter 2026 (Q1 2026).
Was GSK profitable in the first quarter 2026?
Operating profit was $2.2B (29.5% of revenue) and net earnings $1.6B.
Source: GSK 6-K on SEC EDGAR.